Neuromyelitis optica spectrum disorder (NMOSD) and related demyelinating diseases, including myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), represent a spectrum of autoimmune ...

A recent study that applied new criteria for diagnosing neuromyelitis optica spectrum disorders in the absence of serum aquaporin 4 antibodies highlights difficulties with clinical application of ...

In an exploratory study, serum levels of glial fibrillary acidic protein (GFAP) appeared to be predictive of disease severity and prognosis in patients with aquaporin-4 (AQP4)-immunoglobulin G (IgG) ...

Neuromyelitis optica (NMO) can be a devastating rare disease, but a lack of awareness among doctors means patients are often misdiagnosed for years, while research into cures is sparse. After being ...

Neuromyelitis optica-related disorder (NMORD) consists of a spectrum of diseases characterized by recurrent optic neuritis and/or myelitis, with most cases being associated with a pathogenic antibody ...

A "milestone" discovery that an antibody is associated with a wider range of life-threatening autoimmune diseases than previously thought offers new hope for improved diagnosis and treatment in ...

ROCHESTER, Minn. -- Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease (IDD) but may be ...

Multiple sclerosis (MS) is a disease in which the body’s immune system attacks myelin, the outside layer of nerve cells. Neuromyelitis optica (NMO) is also an immune system attack. However, in this ...